All In MedTech

Device Trial Radar · NCT06067360

Evaluation of Performance of New IFIS Sleeve

Hydrodissection Sleeve to Aid Cataract Surgery

Last checked: Nov 20, 2026Latest source record: Oct 4, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

20

Planned (sponsor's estimate)

Start

Feb 2024

Primary completion

Oct 2024

Study completion Nov 2024

Sponsor

Lead sponsor
Medicel AGNot on our public-company list
Sponsor type
Industry
First posted
Oct 4, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A silicone sleeve will be used on the hydrodissection needle to avoid that the iris can prolaps through the gap between needle and incision wound.

Conditions

  • Cataract

Interventions

  • IFIS sleeveDevice

    IFIS sleeve will be inserted to prevent iris prolapse

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. performance of IFIS sleeve to prevent iris prolapseTime frame: The evaluation of the device is during cataract surgery, which typically is less than 10 minutes. No additional treatments or evaluations after the surgery.

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.